![](/img/cover-not-exists.png)
Cost analysis of switching from IV vancomycin to PO linezolid for the management of methicillin-resistant Staphylococcus species
Marianne McCollum, David C. Rhew, Stephen ParodiVolume:
25
Year:
2003
Language:
english
DOI:
10.1016/s0149-2918(03)90101-9
File:
PDF, 105 KB
english, 2003